1 |
Akrami, R., Gharaei, A., Mansour, M. R. and Galeshi, A. 2015. Effects of dietary onion (Allium cepa) powder on growth, innate immune response and hemato-biochemical parameters of beluga (Huso huso Linnaeus, 1754) juvenile. Fish Shellfish Immunol. 45, 828-834.
DOI
|
2 |
Cho, M. S. 2010. Production optimization of spore and macrolatin A from Bacillus polyfermenticus KJS-2. Master. dissertation, Inje university, Kimhae, Korea.
|
3 |
Choi, S. M., Park, M. H., Jung, T. S., Moon, K. H., Kim, K. M. and Kang, J. S. 2011. Characterization of Bacillus mojavensis KJS-3 for industrial applications. Arch. Pharm. Res. 34, 289-298.
DOI
|
4 |
El-Demerdash, F. M., Yousef, M. I. and El-Naga, N. I. 2005. Biochemical study on the hypoglycemic effects of onion and garlic in alloxan-induced diabetic rats. Food Chem. Toxicol. 43, 57-63.
DOI
|
5 |
Endo, A. 1992. The discovery and development of HMG-CoA reductase inhibitors. J. Lipid Res. 33, 1569-1582.
DOI
|
6 |
Grundy, S. M. 1998. Statin trials and goals of cholesterol-lowering therapy. Circulation 97, 1436-1439.
DOI
|
7 |
Kim, D. H., Kang, K. R., Kim, H. W., Yoon, S. Y., Kim, C. G., Yamaguchi, T., Kyung, S. J. and Kang, J. S. 2010. Structure determination of macrolactin compounds with antibacterial activities isolated from Bacillus polyfermenticus KJS2. J. Life Sci. 20, 1792-1800.
DOI
|
8 |
Huang, X., Wu, X., Yan, S. and Lan, T. 2018. Lipid-lowering effect of propolis in mice with triton-WR1339-induced hyperlipidemia and its mechanism for regulating lipid metabolism. Nan. Fang. Yi. Ke. Da. Xue. Xue. Bao. 38, 1020-1024.
|
9 |
Jun, K. D., Kim, H. J., Lee, K. H., Paik, H. D. and Kang, J. S. 2002. Characterization of Bacillus polyfermenticus SCD as a probiotic. Kor. J. Microbiol. Biotechnol. 30, 359-366.
|
10 |
Kawamoto, S., Kawamura, T., Miyazaki, Y. and Hosoya, T. 2007. Effects of atorvastatin on hyperlipidemia in kidney disease patients. Nihon Jinzo Gakkai Shi. 49, 41-48.
|
11 |
Kim, D. H., Kim, H. K., Kim, K. M., Kim, C. K., Jeong, M. H., Ko, C. Y., Moon, K. H. and Kang, J. S. 2011. Antibacterial activities of macrolactin A and 7-O-succinyl macrolactin A from Bacillus polyfermenticus KJS-2 against vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus. Arch. Pharm. Res. 34, 147-152.
DOI
|
12 |
Kim, K. M., Kim, B. S. and Kang, J. S. 2018. The preventive effect of Bacillus polyfermenticus KJS-2 and Angelica gigas Nakai extract on Triton WR-1339-induced hyperlipidemia. J. Life Sci. 28, 726-732.
DOI
|
13 |
Sonmez, O. and Sonmez, M. 2017. Role of platelets in immune system and inflammation. Proto. Biomed. J. 2, 311-314.
DOI
|
14 |
Kim, K. M., Kim, D. H., Park, Y. S. and Kang, J. S. 2009. Characterization of Bacillus polyfermenticus KJS-2 as a Probiotic. J. Microbiol. Biotechnol. 19, 1013-1018.
DOI
|
15 |
Kwon, R. H. and Ha, B. J. 2014. Protection of Saururus Chinensis extract against liver oxidative stress in rats of Triton WR-1339-induced hyperlipidemia. Toxicol. Res. 30, 291-296.
DOI
|
16 |
Lennernas, H. 2003. Clinical pharmacokinetics of atorvastatin. Clin. Pharmacokinet. 42, 1141-1160.
DOI
|
17 |
Park, Y. H., Lee, J. S. and Lee, Y. J. 1993. Distribution of serum lipid by age and the relation of serum lipid to degree of obesity and blood pressure in Korean adults. Kor. J. Lipidiology 3, 165-180.
|
18 |
Pearlman, B. L. 2002. The new cholesterol guidelines. Applying them in clinical practice. Postgrad. Med. 112, 13-48.
DOI
|
19 |
Takahashi, A., Sekiya, C., Yazaki, Y., Ono, M., Sato, H., Hasebe, C., Ishikawa, Y., Okuno, K., Yamada, M. and Namiki, M. 1986. Hepatic GOT and GPT activities in patients with various liver diseases-especially alcoholic liver disease. Hokkaido Igaku Zasshi 61, 431-436.
|
20 |
Vetsika, E. K., Koukos, A. and Kotsakis, A. 2019. MyeloidDerived suppressor cells: major figures that shape the immunosuppressive and angiogenic network in cancer. Cells 8, 1647.
DOI
|
21 |
Virginia, A., Rachmawati, H., Riani, C. and Retnoningrum, D. S. 2016. Study of HMG-CoA reductase inhibition activity of the hydrolyzed product of snakehead fish (Channa striata) skin collagen with 50 kDa collagenase from Bacillus licheniformis F11.4. Sci. Pharm. 84, 81-88.
DOI
|
22 |
Wierzbicki, A. S. 2003. New lipid-lowering agents. Expert Opin. Emerg. Drugs 8, 365-376.
DOI
|
23 |
Nguyen, P., Leray, V., Diez, M., Serisier, S., Le Bloc'h, J., Siliart, B. and Dumon, H. 2008. Liver lipid metabolism. J. Anim. Physiol. Anim. Nutr. 92, 272-283.
DOI
|
24 |
Zarzecki, M. S., Araujo, S. M., Bortolotto, V. C., Paula, M. T., Jesse, C. R. and Prigol, M. 2014. Hypolipidemic action of chrysin on Triton WR-1339-induced hyperlipidemia in female C57BL/6 mice. Toxicol. Rep. 12, 200-208.
|